Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, September 16, 2022
[ Fri, Sep 16th 2022
] - WOPRAI
[ Fri, Sep 16th 2022
] - WOPRAI
[ Fri, Sep 16th 2022
] - WOPRAI
[ Fri, Sep 16th 2022
] - WOPRAI
[ Fri, Sep 16th 2022
] - WOPRAI
[ Fri, Sep 16th 2022
] - WOPRAI
Thu, September 15, 2022
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
[ Thu, Sep 15th 2022
] - WOPRAI
Reni Benjamin Initiated (BCAB) at Buy and Held Target at $17 on, Sep 15th, 2022
Reni Benjamin of JMP Securities, Initiated "BioAtla, Inc." (BCAB) at Buy and Held Target at $17 on, Sep 15th, 2022.
Reni has made no other calls on BCAB in the last 4 months.
There are 2 other peers that have a rating on BCAB. Out of the 2 peers that are also analyzing BCAB, 1 agrees with Reni's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tiago Fauth of "Credit Suisse" Maintained at Hold with Decreased Target to $4 on, Wednesday, August 10th, 2022
This is the rating of the analyst that currently disagrees with Reni
- Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $20 on, Wednesday, August 10th, 2022
